A Computational Approach for Identifying Synergistic Drug Combinations

Kaitlyn M. Gayvert; Omar Aly; James Platt; Marcus W. Bosenberg; David F. Stern; Olivier Elemento

doi:10.1371/journal.pcbi.1005308

Loading metrics

Open Access

Peer-reviewed

Research Article

A Computational Approach for Identifying Synergistic Drug Combinations

Kaitlyn M. Gayvert,

Affiliations Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, United States of America, Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States of America, Tri-Institutional Graduate Program on Computational Biology and Medicine, New York, NY, United States of America
⨯
Omar Aly,

Affiliations Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, United States of America, Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States of America
⨯
James Platt,

Affiliations Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, United States of America

http://orcid.org/0000-0002-4286-446X

⨯
Marcus W. Bosenberg,

Affiliations Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
David F. Stern,

Affiliation Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Olivier Elemento

* E-mail: ole2001@med.cornell.edu

Affiliations Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, United States of America, Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States of America
⨯

A Computational Approach for Identifying Synergistic Drug Combinations

Kaitlyn M. Gayvert,
Omar Aly,
James Platt,
Marcus W. Bosenberg,
David F. Stern,
Olivier Elemento

Published: January 13, 2017
https://doi.org/10.1371/journal.pcbi.1005308

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Synergy testing
Is the Subject Area "Synergy testing" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
High throughput screening
Is the Subject Area "High throughput screening" applicable to this article?

Thanks for your feedback.
Melanoma cells
Is the Subject Area "Melanoma cells" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.